Article Text

Download PDFPDF

Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Seyfrid M, Maich WT, Shaikh VM, et al. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. J Immunother Cancer 2022;10:e003289. doi: 10.1136/jitc-2021-003289.

This article has been corrected since it was first published to correct author name Muhammad Vaseem Shaikh.